Document Type : Original Article

Authors

1 Pharmacy student, Razi Herbal Medicines Research Center, School of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran

2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

3 Lorestan Heart Center (Madani Hospital), Lorestan University of Medical Sciences, Khorramabad, Iran

4 Cardiovascular Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran

5 Department of Biostatistics and Epidemiology, School of Health and Nutrition, Lorestan University of Medical Sciences, Khorramabad, Iran

6 Department of Clinical Laboratory Sciences, School of Allied Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

7 Razi Herbal Medicines Research Center, Shahid Madani Hospital, School of Pharmacy, Lorestan University of Medical Sciences, Khorramabad, Iran

8 General Physician, School of Medicine, Lorestan University of Medical Science, Khorramabad, Iran

Abstract

BACKGROUND: The use of contrast media in angiography has risen alongside the increasing incidence of cardiovascular diseases. Contrast agents cause acute kidney injury due to increased oxidative stress. Antioxidants such as crocin may help prevent contrast-induced acute kidney injury (CI-AKI).
METHODS: A randomized controlled clinical trial involved 60 patients over 18 years old undergoing Percutaneous Coronary Intervention (PCI). Standard hydration therapy was administered to the patients in both groups. The intervention group received 30 mg crocin three consecutive times. Oxidative stress levels and antioxidant system activity were measured, including malondialdehyde (MDA), reactive oxygen species (ROS), glutathione peroxidase (GPx), catalase (CAT), and superoxide dismutase (SOD). The prevalence of CI-AKI was also examined by measuring serum creatinine (SCr), blood urea nitrogen (BUN), and the estimated glomerular filtration rate (eGFR). 
RESULTS: The analysis found no statistically significant differences between the groups for the GPx, CAT, MDA, ROS, SOD, SCr, BUN, and eGFR indices (P > 0.05). The study found a significant decrease in the average SCr and BUN in the intervention group post-PCI (P < 0.05). There were two incidences of CIN in the control group and none in the intervention group; however, the two groups did not differ significantly (P = 0.492). Conclusion: Although oral administration of 30 mg of crocin did not lead to significant changes in oxidant biomarkers, the capacity of the antioxidant defense system tended to increase. Moreover, SCr, BUN, and the incidence of CI-AKI were lower in the intervention group.

Keywords

1. Khan SU, Agarwal S, Arshad HB, Akbar UA, Mamas MA, Arora S, Baber U, Goel SS, Kleiman NS, Shah AR. Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2023 Nov 16;383:e077848. https://doi.org/10.1136/bmj-2023-077848
2. Emami M, Shafie D, Vakhshoori M, Eghbali-Babadi M, Ahmadipour E, Khosravi A. Evaluation of the efficiency of indirect blood pressure measurement methods in comparison to intra-arterial reading among Iranian individuals. Int Cardiovasc Res J. 2020;14(3).
3. Ahmad Y, Petrie MC, Jolicoeur EM, Madhavan MV, Velazquez EJ, Moses JW, et al. PCI in Patients With Heart Failure: Current Evidence, Impact of Complete Revascularization, and Contemporary Techniques to Improve Outcomes. J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100020. https://doi.org/10.1016/j.jscai.2022.100020
4. Health AS. Appropriate Use Criteria: Percutaneous Coronary Intervention. Cardiology. 2022:1–15.
5. Zadeh FJ, Ghasemi Y, Bagheri S, Maleknia M, Davari N, Rezaeeyan H. Do exosomes play role in cardiovascular disease development in hematological malignancy? Mol Biol Rep. 2020 Jul;47(7):5487-93. https://doi.org/10.1007/s11033-020-05453-z
6. Khan SQ, Ludman PF. Percutaneous coronary intervention. Medicine. 2022;50(7):437-44. https://doi.org/10.1016/j.mpmed.2022.04.008
7. Roczniak J, Koziołek W, Piechocki M, Tokarek T, Surdacki A, Bartuś S, et al. Comparison of Access Site-Related Complications and Quality of Life in Patients after Invasive Cardiology Procedures According to the Use of Radial, Femoral, or Brachial Approach. Int J Environ Res Public Health. 2021 Jun 7;18(11):6151. https://doi.org/10.3390/ijerph18116151
8. Senguttuvan NB, Reddy PM, Shankar P, Abdulkader RS, Yallanki HP, Kumar A, et al. Trans-radial approach versus trans-femoral approach in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An updated meta-analysis of randomized controlled trials. PLoS One. 2022 Apr 28;17(4):e0266709. https://doi.org/10.1371/journal.pone.0266709
9. Samadzadeh Etehadi S. Determination of bacterial profiles in children with otitis media with effusion and adenoid hypertrophy. Afr J Biomed Res. 2025;28(2S):470-80. https://doi.org/10.53555/AJBR.v28i2S.6650
10. Alqallaf SM, Al-Jowder M, Abdulla S. Iodixanol induced allergy: a retrospective study at Mohammed Bin Khalifa Cardiac Centre, Kingdom of Bahrain. J Appl Pharm Sci. 2021;11(12):209-15. https://dx.doi.org/10.7324/JAPS.2021.1101221
11. Boozari M, Hosseinzadeh H. Preventing contrast-induced nephropathy (CIN) with herbal medicines: A review. Phytother Res. 2021 Mar;35(3):1130-1146. https://doi.org/10.1002/ptr.6880
12. Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020 Oct 15;259:118379. https://doi.org/10.1016/j.lfs.2020.118379
13. Li Y, Wang J. Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment. BMC Nephrol. 2024 Apr 22;25(1):140. https://doi.org/10.1186/s12882-024-03570-6
14. Chandiramani R, Cao D, Nicolas J, Mehran R. Contrast-induced acute kidney injury. Cardiovasc Interv Ther. 2020 Jul;35(3):209-17. https://doi.org/10.1007/s12928-020-00660-8
15. Kusirisin P, Chattipakorn SC, Chattipakorn N. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches. J Transl Med. 2020 Oct 20;18(1):400. https://doi.org/10.1186/s12967-020-02574-8
16. Pistolesi V, Regolisti G, Morabito S, Gandolfini I, Corrado S, Piotti G, et al. Contrast medium induced acute kidney injury: a narrative review. J Nephrol. 2018 Dec;31(6):797-812. https://doi.org/10.1007/s40620-018-0498-y
17. Sabaghian T, Gheydari ME, Divani F. Evaluation of Curcumin (Turmeric Extract) Effect on Prevention of CIN in Patient Under Elective Coronary Angiography, a Randomized Double Blind Placebocontrolled Clinical Trial. Iran J Kidney Dis. 2020 May;14(3):198-205.
18. Zhao J, Liu H, Xu B, Peng J, Xing Y, Tang W, et al. The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention. Evid Based Complement Alternat Med. 2020 Apr 27;2020:5419016. https://doi.org/10.1155/2020/5419016
19. Aksoy F, Aydın Baş H, Bağcı A, Basri Savaş H. Predictive value of oxidant and antioxidant status for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Rev Port Cardiol (Engl Ed). 2021 Jul;40(7):489-97. https://doi.org/10.1016/j.repce.2021.07.018
20. Cervantes-Gracia K, Raja K, Llanas-Cornejo D, Cobley JN, Megson IL, Chahwan R, Husi H. Oxidative stress and inflammation in the development of cardiovascular disease and contrast induced nephropathy. Vessel Plus. 2020;4:27. http://dx.doi.org/10.20517/2574-1209.2020.22
21. Boozari M, Hosseinzadeh H. Natural medicines for acute renal failure: A review. Phytother Res. 2017 Dec;31(12):1824-35. https://doi.org/10.1002/ptr.5943
22. Ghiasian M, Khamisabadi F, Kheiripour N, Karami M, Haddadi R, Ghaleiha A, et al. Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double-blind, randomized, and placebo-controlled trial. J Biochem Mol Toxicol. 2019 Dec;33(12):e22410. https://doi.org/10.1002/jbt.22410
23. Korani S, Korani M, Sathyapalan T, Sahebkar A. Therapeutic effects of Crocin in autoimmune diseases: A review. Biofactors. 2019 Nov;45(6):835-43. https://doi.org/10.1002/biof.1557
24. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. https://doi.org/10.1016/j.jacc.2004.06.068
25. Sgura FA, Bertelli L, Monopoli D, Leuzzi C, Guerri E, Spartà I, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv. 2010 Oct;3(5):491-8. https://doi.org/10.1161/circinterventions.110.955310
26. Kielkopf CL, Bauer W, Urbatsch IL. Bradford Assay for Determining Protein Concentration. Cold Spring Harb Protoc. 2020 Apr 1;2020(4):102269. https://doi.org/10.1101/pdb.prot102269
27. Esfandiari N, Sharma RK, Saleh RA, Thomas AJ Jr, Agarwal A. Utility of the nitroblue tetrazolium reduction test for assessment of reactive oxygen species production by seminal leukocytes and spermatozoa. J Androl. 2003 Nov-Dec;24(6):862-70. https://doi.org/10.1002/j.1939-4640.2003.tb03137.x
28. Ahmadvand H, Dehnoo MG, Cheraghi R, Rasoulian B, Ezatpour B, Azadpour M, et al. Amelioration of altered serum, liver, and kidney antioxidant enzymes activities by sodium selenite in alloxan-induced diabetic rats. Rep Biochem Mol Biol. 2014 Oct;3(1):14-20.
29. Nasiry D, Khalatbary AR, Ahmadvand H, Talebpour Amiri FB. Effects of Juglans regia L. leaf extract supplementation on testicular functions in diabetic rats. Biotech Histochem. 2021 Jan;96(1):41-7. https://doi.org/10.1080/10520295.2020.1755893
30. Nasri M, Adibhesami G, Mahdavifard S, Babaeenezhad E, Ahmadvand H. Exogenous glutamine ameliorates diabetic nephropathy in a rat model of type 2 diabetes mellitus through its antioxidant and anti-inflammatory activities. Arch Physiol Biochem. 2023 Apr;129(2):363-72. https://doi.org/10.1080/13813455.2020.1828478
31. Martin JP Jr, Dailey M, Sugarman E. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys. 1987 Jun;255(2):329-36. https://doi.org/10.1016/0003-9861(87)90400-0
32. Manda P, Rao PS, Bitla AR, Vinapamula KS, Jeyaseelan L, Rajasekhar D, et al. Study of contrast-induced oxidative stress in nondiabetic patients undergoing coronary angiography. Saudi J Kidney Dis Transpl. 2019 Jan-Feb;30(1):45-52.
33. Rahiman N, Akaberi M, Sahebkar A, Emami SA, Tayarani-Najaran Z. Protective effects of saffron and its active components against oxidative stress and apoptosis in endothelial cells. Microvasc Res. 2018 Jul;118:82-9. https://doi.org/10.1016/j.mvr.2018.03.003
34. Yousefsani BS, Pourahmad J, Hosseinzadeh H. The mechanism of protective effect of crocin against liver mitochondrial toxicity caused by arsenic III. Toxicol Mech Methods. 2018 Feb;28(2):105-14. https://doi.org/10.1080/15376516.2017.1368054
35. Jalili C, Ghanbari A, Roshankhah S, Salahshoor MR. Toxic Effects of Methotrexate on Rat Kidney Recovered by Crocin as a Consequence of Antioxidant Activity and Lipid Peroxidation Prevention. Iran Biomed J. 2020 Jan;24(1):39-46. https://doi.org/10.29252/ibj.24.1.39
36. Naghizadeh B, Mansouri SM, Mashhadian NV. Crocin attenuates cisplatin-induced renal oxidative stress in rats. Food Chem Toxicol. 2010 Oct;48(10):2650-5. https://doi.org/10.1016/j.fct.2010.06.035
37. Yarijani ZM, Najafi H, Hamid Madani S. Protective effect of crocin on gentamicin-induced nephrotoxicity in rats. Iran J Basic Med Sci. 2016 Mar;19(3):337-43.
38. Firuzi O, Miri R, Tavakkoli M, Saso L. Antioxidant therapy: current status and future prospects. Curr Med Chem. 2011;18(25):3871-88. https://doi.org/10.2174/092986711803414368
39. Behrouz V, Sohrab G, Hedayati M, Sedaghat M. Inflammatory markers response to crocin supplementation in patients with type 2 diabetes mellitus: A randomized controlled trial. Phytother Res. 2021 Jul;35(7):4022-31. https://doi.org/10.1002/ptr.7124